Sarepta Therapeutics Inc (SRPT): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Sarepta Therapeutics ( SRPT) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.1%. By the end of trading, Sarepta Therapeutics rose $0.50 (2.8%) to $18.70 on light volume. Throughout the day, 1,443,157 shares of Sarepta Therapeutics exchanged hands as compared to its average daily volume of 3,124,200 shares. The stock ranged in a price between $18.00-$18.73 after having opened the day at $18.10 as compared to the previous trading day's close of $18.20. Other companies within the Health Care sector that increased today were: Oculus Innovative ( OCLS), up 103.4%, Tonix Pharmaceuticals ( TNXP), up 30.1%, CAS Medical Systems ( CASM), up 28.7% and ARCA biopharma ( ABIO), up 25.0%.

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Sarepta Therapeutics has a market cap of $689.6 million and is part of the drugs industry. Shares are down 28.9% year to date as of the close of trading on Tuesday. Currently there are 7 analysts that rate Sarepta Therapeutics a buy, 2 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Sarepta Therapeutics as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and generally disappointing historical performance in the stock itself.

On the negative front, Ambit Biosciences ( AMBI), down 33.1%, BioTelemetry ( BEAT), down 19.9%, EnteroMedics ( ETRM), down 13.4% and Vanda Pharmaceuticals ( VNDA), down 8.2% , were all laggards within the health care sector with Aetna ( AET) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk